Eqis Capital Management, Inc. Grifols Sa Transaction History

Eqis Capital Management, Inc.

  • $1.21 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$7.71 - $11.56 $6,430 - $9,641
-834 Reduced 6.81%
11,413 $131,000
Q3 2023

Nov 13, 2023
SELL
$8.91 - $10.91 $40,389 - $49,455
-4,533 Reduced 27.01%
12,247 $111,000
Q2 2023

Aug 14, 2023
SELL
$7.14 - $9.29 $8,168 - $10,627
-1,144 Reduced 6.38%
16,780 $153,000
Q1 2023

May 15, 2023
SELL
$6.65 - $10.69 $6,603 - $10,615
-993 Reduced 5.25%
17,924 $132,000
Q4 2022

Feb 14, 2023
SELL
$5.96 - $8.53 $5,060 - $7,241
-849 Reduced 4.3%
18,917 $160,000
Q3 2022

Oct 24, 2022
SELL
$5.95 - $14.3 $5,307 - $12,755
-892 Reduced 4.32%
19,766 $121,000
Q2 2022

Aug 08, 2022
SELL
$10.6 - $13.28 $12,953 - $16,228
-1,222 Reduced 5.59%
20,658 $245,000
Q1 2022

May 16, 2022
SELL
$10.37 - $12.73 $1.05 Million - $1.29 Million
-101,053 Reduced 82.2%
21,880 $256,000
Q4 2021

Feb 14, 2022
BUY
$10.21 - $15.27 $105,336 - $157,540
10,317 Added 9.16%
122,933 $1.38 Million
Q3 2021

Nov 12, 2021
BUY
$14.07 - $17.3 $182,037 - $223,827
12,938 Added 12.98%
112,616 $1.65 Million
Q2 2021

Aug 12, 2021
BUY
$16.62 - $18.94 $377,739 - $430,468
22,728 Added 29.54%
99,678 $1.73 Million
Q1 2021

May 14, 2021
BUY
$15.15 - $19.78 $1.17 Million - $1.52 Million
76,950 New
76,950 $1.33 Million

Others Institutions Holding GRFS

# of Institutions
164
Shares Held
140M
Call Options Held
288K
Put Options Held
389K
View Full List

About Grifols SA

GRFS Quotes by TradingView
  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email